Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

AbbVie’s Skyrizi Wins FDA Approval for Psoriatic Arthritis
AbbVie’s Skyrizi Wins FDA Approval for Psoriatic Arthritis
The FDA has approved AbbVie’s Skyrizi (risankizumab-rzaa) for treating adults with psoriatic arthritis, an inflammatory disease that afflicts an estimated 30 percent of psoriasis sufferers. ...
The FDA expands its approval of remdesivir to patients who are not hospitalized
The FDA expands its approval of remdesivir to patients who are not hospitalized

The treatment must be given via intravenous infusion over three consecutive days, generally at a hospital or clinic.

UCB wins permit to market psoriasis drug in Japan
UCB wins permit to market psoriasis drug in Japan
Belgian pharmaceuticals company UCB has been given permission to market its treatment for psoriasis, Bimzelx (bimekizumab) in Japan, the company announced today. ...
FDA grants fast track status for new Alzheimer’s drug lecanemab
FDA grants fast track status for new Alzheimer’s drug lecanemab
Two health care companies – one based in Massachusetts called Biogen and its Japanese partner Eisai Co. – recently were granted “fast track” approval by the U.S. Food and Drug Administratio...
Elon Musk’s Neuralink is hiring a clinical trial director
Elon Musk’s Neuralink is hiring a clinical trial director
Elon Musk’s brain-machine interface company Neuralink has a new job posting for a clinical trial director, a position that could help the company move towards its stated goal of testing its brain...
Santa Cruz company gets on FDA fast track for pathogen sequencing method approval
Santa Cruz company gets on FDA fast track for pathogen sequencing method approval
Nearly 3,000 devices receive approval from the FDA each year, according to Pathogenomix Chairman Chris Risley, but only 75 receive a Breakthrough Device Designation. ...
MPP Inks Deals With 27 Generics Makers to Produce Merck’s COVID-19 Pill
MPP Inks Deals With 27 Generics Makers to Produce Merck’s COVID-19 Pill
The United Nations-backed Medicines Patent Pool (MPP) has secured agreements with 27 generics makers in Asia and Africa to supply Merck’s COVID-19 oral antiviral, molnupiravir, in 105 low- and mi...
Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection
Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection
In a study published in the latest issue of the journal Materials Today Advances, a team of researchers explored the utilities of graphene (GO) and its derivatives in combating the severe acute res...
Biotech Billionaire Launches Large Vaccine Manufacturing Plant in South Africa
Biotech Billionaire Launches Large Vaccine Manufacturing Plant in South Africa
Patrick Soon-Shiong, South African-born head of biotech firms NantWorks and ImmunityBio, has launched a new manufacturing facility in South Africa with the goal of producing 1 billion COVID-19 vacc...
Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced today that the Company has entered into a drug discovery collaboration with Eli Lilly and Company i...
FDA Grants Fast Track Designation to CYNK-101 for HER2+ Gastric/GEJ Cancers
FDA Grants Fast Track Designation to CYNK-101 for HER2+ Gastric/GEJ Cancers
The FDA has granted a fast track designation to CYNK-101 in combination with standard frontline chemotherapy, trastuzumab, and pembrolizumab for patients with advanced HER2-positive gastric or gast...
Antares Pharma Receives FDA Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue
Antares Pharma Receives FDA Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue
Antares Pharma, Inc. (NASDAQ: ATRS), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ATRS-1902 for adrena...
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand